MINIMED GROUP INC (MMED) is drawing unusual attention today. Our newswire has captured 1 story on MMED across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 73/100).
MiniMed Group Inc (MMED) surged 10.66% to $22.42 in morning trading on September 1, 2026. The move followed a strong first-quarter performance and upgraded analyst expectations. The stock hit a new 52-week high, driven by a raised fiscal 2027 revenue growth outlook and a price target increase from Wells Fargo.
MiniMed reported first-quarter net sales of $843 million, a 16.6% increase year-over-year. The company raised its fiscal 2027 organic revenue growth guidance to approximately 10.5%, citing momentum from the launch of its Flex product and progress toward a U.S. launch of Fit by summer 2027. The CEO described the quarter as an excellent start to the fiscal year and emphasized the company's positioning to accelerate growth. On the same day, Wells Fargo raised its price target for MiniMed to $26 from $22, while BTIG also increased its price target and maintained a "Buy" rating. The stock’s upward momentum was further supported by positive retail trader sentiment and a recent 510(k) filing for Fit.
Over the last eight trading sessions, MMED has gained 10.4%, rising from $20.18 to $22.27. The stock closed Monday at $20.88, just below its 52-week high of $20.88, and now trades at $22.42. The company’s revenue has grown 14.3% in the trailing twelve months, but it remains unprofitable with a net margin of -10.7% and an EPS of -1.30. The stock has a market cap of $5.6 billion and has seen one retail post on social media in the last 24 hours.
MiniMed’s updated fiscal 2027 guidance and product milestones will remain in focus. Investors should monitor the U.S. launch of Fit and continued progress in the Flex product line.
AI-assisted analysis composed exclusively from headlines and data on the Top Tier newswire. Public view is delayed 4 hours from real time. Not financial advice.
On September 1, MiniMed (NASDAQ:MMED) reported its first full quarter as a stand-alone public company, and the numbers suggest the split from Medtronic is already paying off. Revenue jumped 15.8% to $843 million, and management raised its full-year growth outlook just months after the IPO roadshow. The catalyst is simple. A new pump finally shipped, […]
MINIMED GROUP INC (MMED) is drawing unusual attention today. Our newswire has captured 1 story on MMED across 1 source in the last 36 hours, with AI sentiment reading bullish (avg 73/100). The most recent driver: "MiniMed’s (MMED) New Pump Lineup Is Finally Winning Patients Over" (Yahoo Finance).
Top Tier Newswire does not give financial advice. Our AI sentiment across the last 36 hours of MMED coverage reads 73/100 over 1 stories; treat it as a research signal and do your own diligence.
The data sections refresh continuously as the newswire lands coverage; the written analysis is published once per trading day. Pro subscribers additionally get real-time push alerts, watchlists, and the full live terminal.
More on MMED: full news and sentiment history. Sentiment scores are AI-derived research signals, not financial advice.
Earlier MMED move explainers: 2026-09-02 · 2026-09-01 · 2026-08-26 · 2026-08-25